Stocks
Novartis (NVS) ROE US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | 11.7% | 11.7% | 31.8% | 27.1% | 30.5% | 35.1% | ||
| Changes by years, y/y, % | 0pp | 0pp | +20pp | -5pp | +3pp | +16.4% | |||
Novartis. ROE, %
Novartis. ROE, changes, pp
Novartis (NVS) ROE US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| ROE, % | ? | 33.5% | 32.5% | 32.5% | 30.3% | 35.1% | 35.1% | |
| Changes by years, y/y, % | -5pp | -6pp | -8pp | +3pp | +2pp | |||
| Changes by quarters, q/q, % | +6pp | -1pp | 0pp | -2pp | +5pp | |||
